Abstract:
Novel spherulite-containing compositions are described. Methods for making spherulite-containing compositions are also described. Preferred embodiments include compositions comprising a surfactant component, a salt, and an oil phase, wherein the surfactant component comprises (a) about 6 to about 10 weight % sodium trideceth sulfate; (b) about 1.8 to about 3.0 weight % of a structuring agent; (c) about 1.1 to about 3.0 weight % of a foam booster; (d) water; and (e) about 0.2 to about 0.8 weight % of a cationic guar gum.
Abstract:
A process is disclosed for preparing silicone visicle compositions containing a personal care or healthcare active, compositions prepared by the inventive process, and formulated products containing the silicone vesicles.
Abstract:
The present invention comprises cosmetic compositions and methods for retarding hair growth comprising a combination of an ornithine decarboxylase inhibitor, an anti-angiogenic active and an anti-inflammatory.
Abstract:
Provided is a composition of a cosmetic and a manufacturing method thereof which has a mental stability and suppression effect, together with a skin health, in which at least one oil selected from the group consisting of rose otto, neroli, clary sage, geranium, chamomile roman, juniper berry, lavender, sandalwood, majoram, and ylang ylang, cypress, bergamot, frankincense, palmarosa, lemon, vetiver, spikenud, and almond, and the combination thereof all of which are known as substances efficacious for neuromental diseases among natural essential oils which are widely used for an aroma therapy is stably contained in a liquid or fluid cosmetic, using a conventional cosmetic composition.
Abstract:
The invention relates to a process for dissolving at least one lipophilic compound in at least one aqueous phase, characterized in that it comprises the step of associating the said lipophilic compound with an effective amount of at least one amphilic block copolymer comprising at least one ionic and/or at least one nonionic hydrophilic polymer block, and at least one hydrophobic polymer block.
Abstract:
The invention relates to phenolic compounds and the derivatives thereof which are represented by formula I, wherein: R1 and R2 are selected from OH, OCOalkyl or OCOalkenyl; R3 is H, OH, OCOalkyl or OCOalkenyl; the alkyl or alkenyl chains have between 2 and 22 carbon atoms; and at least one OCOalkyl or OCOalkenyl group is present in the structure. More specifically, the invention relates to the use of said compounds for the prevention or treatment of cardiovascular, hepatic and renal diseases and for cosmetic applications. The invention also relates to compositions containing the above-mentioned compounds and to some novel phenolic compounds and the derivatives thereof.
Abstract:
The invention relates to the use of an extract of olive leaves (Olea europaea) which is titrated in oleanolic acid and which may or may not be associated with a Larrea divaricata extract which is titrated in nordihydroguaiaretic acid (NDGA). Said products are intended for all types of cosmetic and dermopharmaceutical compositions for all forms of skin care, for moisturising and anti-inflammatory purposes and, in particular, for the prevention and treatment of skin prone to acne.
Abstract:
The present invention is based on a novel method for encapsulating in liposomes substantialy water immiscible carotenoids. Therefore, there are provided by the present invention formulations comprising liposomes loaded with an amount of at least one water immiscible carotenoid. Pharmaceutical compositions comprising such a formulation, and a method for preparing the liposomes loaded with said carotenoid.
Abstract:
The present invention relates to a composition for topical, oral, nasal, anal, ophthalmic, or vaginal application comprising a base composition and at least one dispersion comprising suspended particles of a hydrophobic active agent, a hydrophobic adjuvant, or a combination thereof. The base composition comprises a rheology modifying agent and water. The composition is substantially free of emulsifying surfactants and the suspended particles generally have a diameter less than about 500 or 1,000 nm. Another embodiment is a method of preparing a composition comprising mixing the aforementioned base composition with the aforementioned dispersion. Mixing may be performed with a propeller mixer or manually, i.e. , by hand. Since the topical dispersion is simple and quick to prepare, custom cosmetic compositions may be prepared at the point of sale for customers. Prior to the present invention, such products would take hours to be prepared. Furthermore, the method of the present invention is significantly more efficient i.e less expensive and faster) than conventional methods for preparing emulsion-based compositions. The present invention further relates to a method of treating topical, oral, nasal, anal, ophthalmic or vaginal disorders with the composition of this invention.
Abstract:
The invention relates to pro-liposomal encapsulated preparations, which can be obtained by treating biogenic active substances in cosmetically acceptable solvents with lecithins and/or phospholipids.